Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,787 | 1 | 74.3% |
| Food and Beverage | $618.38 | 10 | 25.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Brainsway USA INC | $1,787 | 1 | $0 (2022) |
| AbbVie Inc. | $356.21 | 3 | $0 (2023) |
| ITI, Inc. | $97.54 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $92.49 | 1 | $0 (2019) |
| Alkermes, Inc. | $30.25 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.36 | 1 | $0 (2024) |
| Indivior Inc. | $11.61 | 1 | $0 (2019) |
| Shire North American Group Inc | $10.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.68 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($19.36) |
| 2023 | $330.95 | 3 | AbbVie Inc. ($233.41) |
| 2022 | $1,910 | 2 | Brainsway USA INC ($1,787) |
| 2019 | $104.10 | 2 | AstraZeneca Pharmaceuticals LP ($92.49) |
| 2018 | $13.93 | 1 | Alkermes, Inc. ($13.93) |
| 2017 | $10.92 | 1 | Shire North American Group Inc ($10.92) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CNS | ||||||
| 01/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.41 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $97.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2022 | Brainsway USA INC | Brainsway Deep TMS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,787.08 | General |
| Category: Transcranial Magnetic Stimulation | ||||||
| 10/23/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $92.49 | General |
| Category: Oncology | ||||||
| 03/20/2019 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: BH | ||||||
| 11/28/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: CNS | ||||||
| 11/17/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 20 | 40 | $3,600 | $1,261 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 40 | $3,600 | $1,261 | 35.0% |
About Dr. John Simora, D.O
Dr. John Simora, D.O is a Psychiatry healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770776049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Simora, D.O has received a total of $2,405 in payments from pharmaceutical and medical device companies, with $35.68 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,787).
As a Medicare-enrolled provider, Simora has provided services to 20 Medicare beneficiaries, totaling 40 services with total Medicare billing of $1,261. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Bradford, PA
- Active Since 08/21/2007
- Last Updated 10/11/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770776049
Products in Payments
- Brainsway Deep TMS (Device) $1,787
- VRAYLAR (Drug) $356.21
- CAPLYTA (Drug) $97.54
- LYNPARZA (Drug) $92.49
- TRINTELLIX (Drug) $19.36
- ARISTADA (Drug) $16.32
- Aristada 441 mg (Drug) $13.93
- PERSERIS (Drug) $11.61
- MYDAYIS (Drug) $10.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.